Skip to Content

Valeant Is Said to Be Hiring This Zoetis Exec as Its New CFO

Valeant Pharmaceuticals Offices Ahead Of Earnings FiguresValeant Pharmaceuticals Offices Ahead Of Earnings Figures
Valeant Pharmaceuticals International headquarters stands in Bridgewater Township, N.J., on Thursday, Aug. 4, 2016.Photograph by Ron Antonelli — Bloomberg via Getty Images

Animal health company Zoetis (ZTS) said Paul Herendeen resigned as its chief financial officer (CFO) and the company promoted Glenn David as its new CFO.

Zoetis said Herendeen left the company effective Aug. 18 to accept the position of CFO at another public company.

Valeant Pharmaceuticals International (VRX) is expected to announce it has hired Herendeen as its new CFO, the Wall Street Journal reported on Sunday, citing sources.

See also: Here’s Why Shares of Valeant are Soaring

David is currently senior vice president of finance operations at Zoetis.

Zoetis, which was spun off from Pfizer in 2013, is engaged in the discovery, development, manufacture and marketing of animal health medicines and vaccines, with a focus on both livestock and companion animals.